BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
May 6, 2026
Company
BIOCRYST PHARMACEUTICALS INC (BCRX)
Other upcoming events for BCRX
Phase 3 Readout
Phase 3 Topline: A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children
Feb 1, 2027
Patent Expiry
Patent/Exclusivity Expiry: ORLADEYO
Nov 1, 2039
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
BCRX Overview
PDUFA Dates
Phase 3 Readouts
Earnings Report — BCRX Earnings Report | BioSniper